It took nearly 10 years of research and development to design, evaluate and validate the Noratest® product. Alzohis has surrounded itself with the greatest neurologists and specialists in Alzheimer's disease to develop this diagnostic test. In an iterative process, the Noratest® product has been refined to optimise its accuracy based on findings from several clinical studies that comprised blood samples from hundreds of patients with well-defined and diverse clinical, demographic and physiological parameters. Recently, Alzohis has been fortunate to have its research work dedicated to its latest clinical study. Noratest®'s CE marking was filed in 2019, it materializes the manufacturer's commitment to comply with the highest legal, normative and regulatory requirements.